Morgan Stanley Maintains Underweight on Dabur India with ₹412 Target Price

2 min read     Updated on 06 Apr 2026, 08:58 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Morgan Stanley maintains its Underweight rating on Dabur India with a target price of ₹412, acknowledging the company's Q4 FY26 performance with mid-single digit revenue growth and EBITDA growth of approximately 6% YoY. While domestic demand shows sequential improvement to high-single digits, the brokerage remains cautious due to Middle-East disruptions from geopolitical tensions affecting international operations.

powered bylight_fuzz_icon
36765561

*this image is generated using AI for illustrative purposes only.

Dabur India Limited faces mixed analyst sentiment as Morgan Stanley maintains its Underweight rating with a target price of ₹412, despite the company's steady Q4 FY26 performance. The brokerage firm cites mid-single digit revenue growth and geopolitical headwinds affecting international operations as key concerns, even as domestic demand shows sequential improvement.

Morgan Stanley's Assessment

Morgan Stanley's analysis highlights several key factors influencing their cautious stance on Dabur India:

Rating Parameter: Details
Rating: Underweight
Target Price: ₹412
Q4 Revenue Growth: Mid-single digit
EBITDA Growth: ~6.00% YoY (ahead of revenue)

The brokerage acknowledges the sequential improvement in domestic demand to high-single digits but remains concerned about the Middle-East disruption from geopolitical tensions and maintains a cautious near-term outlook despite gradual domestic recovery.

Q4 FY26 Performance Highlights

Dabur India's Q4 FY26 update shows consolidated revenues growing in mid-single digits with operating profit growing ahead of the topline. The India FMCG business demonstrated resilience with sequential recovery in demand, likely to record high-single digit growth during the quarter.

Business Segment: Expected Growth Key Performance Drivers
India FMCG Business: High-single digit Sequential recovery in demand
Home & Personal Care: Mid-teens Hair Oils, Shampoo, Home Care
Healthcare: Low-single digit Mixed performance across portfolio
F&B Vertical: Low-single digit Sequential improvement

Home & Personal Care Drives Growth

The Home & Personal care business sustained its double-digit growth trajectory and is expected to grow in mid-teens. This growth is anticipated to be led by Hair Oils, Shampoo and Home Care categories, which are likely to record growth in twenties. Key brands expected to report healthy volume-led growth include Dabur Amla franchise, Vatika Shampoo, Dabur Almond, Odonil, Odomos, Meswak, and Gulabari.

International Challenges Impact Outlook

The international business faced significant headwinds, particularly in the Middle East due to the US-Israel-Iran conflict impact. While other key markets including Turkey, Bangladesh and UK performed well with double-digit growth in constant currency terms, the company expects its international business to record low-single digit growth in INR terms.

Channel Type: Performance Status
Organised Trade: Maintained growth momentum
Modern Trade: Continued strong performance
E-commerce: Sustained growth trajectory
General Trade: Steady recovery witnessed

Despite the gradual domestic recovery and sequential improvement in demand, Morgan Stanley's cautious stance reflects concerns about geopolitical disruptions and their impact on the company's international operations, particularly in the strategically important Middle East markets.

Historical Stock Returns for Dabur India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.41%+1.91%+7.28%-11.22%-6.65%-16.42%

How might escalating geopolitical tensions in the Middle East further impact Dabur's international revenue trajectory in FY27?

Will Dabur's strong performance in hair oils and home care categories be sustainable amid increasing competition from local and multinational brands?

Could Dabur accelerate its expansion in high-growth markets like Turkey and Bangladesh to offset Middle East disruptions?

Dabur India Publishes Hindi Notice for Sesa Care Merger Meetings on May 2, 2026

2 min read     Updated on 01 Apr 2026, 10:15 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dabur India has published an official Hindi notice in Jansatta newspaper for virtual meetings scheduled on May 2, 2026, seeking approval for the proposed Scheme of Amalgamation with Sesa Care Private Limited. The meetings are scheduled pursuant to NCLT order dated March 12, 2026, with equity shareholders meeting at 11:00 AM and unsecured creditors meeting at 1:00 PM, both conducted through VC/OAVM with e-voting facilities provided by NSDL.

powered bylight_fuzz_icon
36422058

*this image is generated using AI for illustrative purposes only.

Dabur India has published an official Hindi notice in Jansatta newspaper regarding the upcoming meetings for equity shareholders and unsecured creditors scheduled for May 2, 2026, to seek approval for the proposed Scheme of Amalgamation with Sesa Care Private Limited. The company issued this notice under reference SEC/SE/2026-27 dated April 01, 2026, in continuation to their earlier communication dated March 31, 2026.

NCLT Order Facilitates Merger Process

The meetings have been scheduled pursuant to an order dated March 12, 2026, passed by the Hon'ble NCLT, New Delhi Bench in Company Application No. (CAA) – 1(ND)/2026. This represents a crucial regulatory milestone in the merger proceedings, indicating that the proposed corporate restructuring has progressed through the necessary legal and regulatory channels required for such transactions under Sections 230 to 232 of the Companies Act, 2013.

Meeting Schedule and Regulatory Framework

Dabur India issued the official notice to stock exchanges BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI Listing Regulations. The communication outlines the comprehensive regulatory framework governing the proposed Scheme of Amalgamation between Sesa Care Private Limited (Transferor Company) and Dabur India Limited (Transferee Company).

Meeting Details: Information
Date: May 2, 2026
Equity Shareholders Time: 11:00 AM (IST)
Unsecured Creditors Time: 1:00 PM (IST)
Format: VC/OAVM (Virtual)
Purpose: Merger Approval
Target Company: Sesa Care Private Limited
NCLT Order Date: March 12, 2026
Application No.: (CAA) – 1(ND)/2026
Reference Number: SEC/SE/2026-27

Hindi Publication and Document Accessibility

The company has published the notice in Hindi language in the Jansatta newspaper (Hindi edition) on April 01, 2026, ensuring wider accessibility for stakeholders. The copy of the newspaper publication is being made available on the company's official website at www.dabur.com to ensure maximum accessibility. The meetings are being conducted in accordance with applicable general circulars issued by the Ministry of Corporate Affairs regarding conducting meetings through VC/OAVM with e-voting facility.

Digital Infrastructure and Compliance Framework

To facilitate comprehensive participation, Dabur India has implemented digital mechanisms for the upcoming meetings in compliance with Section 108 and other applicable provisions of the Companies Act, 2013. The company has appointed National Securities Depository Limited (NSDL) to provide remote e-voting facilities, enabling equity shareholders and unsecured creditors to cast their votes electronically on the merger proposal. The notice was signed by Ashok Kumar Jain, Group Company Secretary and Chief Compliance Officer.

Tribunal Appointments and Next Steps

The NCLT has appointed Dr. Shashank Saksena as the Chairperson for both meetings, including any adjournments thereof, and Mr. Pratish Sinha (Advocate) as the Scrutinizer. The proposed Scheme, if approved at the meetings, will be subject to subsequent approval of the Tribunal and such approvals, permissions and sanctions of regulatory or other authorities as may be necessary for the completion of the amalgamation process.

Historical Stock Returns for Dabur India

1 Day5 Days1 Month6 Months1 Year5 Years
-0.41%+1.91%+7.28%-11.22%-6.65%-16.42%

What strategic synergies does Dabur expect to achieve through the merger with Sesa Care Private Limited?

How might this amalgamation impact Dabur's market positioning in the FMCG and healthcare sectors?

What potential regulatory hurdles could delay the final tribunal approval beyond the May 2026 meetings?

More News on Dabur India

1 Year Returns:-6.65%